Di Nuzzo Private Wealth, Inc. Bridge Bio Pharma, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 29 shares of BBIO stock, worth $1,112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 17
70.59%
Holding current value
$1,112
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
322Shares Held
178MCall Options Held
12.8MPut Options Held
2.51M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$969 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$964 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$578 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$478 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$237 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.69B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...